Federated Hermes’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $21.2M | Buy |
98,315
+1,036
| +1% | +$198K | 0.03% | 482 |
|
|
2026
Q1 | $17.8M | Sell |
97,279
-33,889
| -26% | -$6.24M | 0.03% | 498 |
|
|
2025
Q4 | $23.1M | Buy |
131,168
+6,246
| +5% | +$1.02M | 0.04% | 427 |
|
|
2025
Q3 | $17.5M | Buy |
124,922
+4,645
| +4% | +$628K | 0.03% | 449 |
|
|
2025
Q2 | $15.1M | Buy |
120,277
+17,069
| +17% | +$2.13M | 0.03% | 488 |
|
|
2025
Q1 | $14.1M | Buy |
103,208
+1,805
| +2% | +$258K | 0.03% | 478 |
|
|
2024
Q4 | $15.5M | Sell |
101,403
-1,181
| -1% | -$199K | 0.03% | 457 |
|
|
2024
Q3 | $19.9M | Sell |
102,584
-358
| -0.3% | -$74.9K | 0.04% | 428 |
|
|
2024
Q2 | $23.9M | Buy |
102,942
+218
| +0.2% | +$47.4K | 0.06% | 365 |
|
|
2024
Q1 | $22.2M | Buy |
102,724
+2,576
| +3% | +$603K | 0.05% | 394 |
|
|
2023
Q4 | $25.9M | Sell |
100,148
-4,320
| -4% | -$1.06M | 0.06% | 334 |
|
|
2023
Q3 | $26.8M | Buy |
104,468
+44,328
| +74% | +$11.9M | 0.07% | 303 |
|
|
2023
Q2 | $17.1M | Sell |
60,140
-2,731
| -4% | -$813K | 0.04% | 423 |
|
|
2023
Q1 | $17.5M | Buy |
62,871
+250
| +0.4% | +$69.2K | 0.04% | 428 |
|
|
2022
Q4 | $17.3M | Sell |
62,621
-72,028
| -53% | -$20.3M | 0.05% | 417 |
|
|
2022
Q3 | $36M | Sell |
134,649
-177,323
| -57% | -$37.7M | 0.11% | 238 |
|
|
2022
Q2 | $63.6M | Buy |
311,972
+91,985
| +42% | +$18.8M | 0.17% | 153 |
|
|
2022
Q1 | $46.3M | Buy |
219,987
+150,537
| +217% | +$32.7M | 0.1% | 241 |
|
|
2021
Q4 | $16.7M | Buy |
69,450
+64,015
| +1,178% | +$16.5M | 0.03% | 532 |
|
|
2021
Q3 | $1.54M | Sell |
5,435
-152
| -3% | -$49.8K | ﹤0.01% | 1124 |
|
|
2021
Q2 | $1.94M | Sell |
5,587
-1,792
| -24% | -$543K | ﹤0.01% | 1110 |
|
|
2021
Q1 | $2.06M | Sell |
7,379
-61,203
| -89% | -$16.5M | ﹤0.01% | 1094 |
|
|
2020
Q4 | $16.8M | Sell |
68,582
-43,012
| -39% | -$11.1M | 0.03% | 512 |
|
|
2020
Q3 | $31.7M | Sell |
111,594
-91,748
| -45% | -$25.6M | 0.07% | 299 |
|
|
2020
Q2 | $54.4M | Buy |
203,342
+58,606
| +40% | +$17.6M | 0.13% | 177 |
|
|
2020
Q1 | $45.8M | Sell |
144,736
-14,130
| -9% | -$4.29M | 0.13% | 170 |
|
|
2019
Q4 | $47.1M | Sell |
158,866
-161,853
| -50% | -$44.9M | 0.11% | 229 |
|
|
2019
Q3 | $74.7M | Buy |
320,719
+54,821
| +21% | +$12.8M | 0.18% | 127 |
|
|
2019
Q2 | $62.2M | Buy |
265,898
+51,424
| +24% | +$11.9M | 0.15% | 154 |
|
|
2019
Q1 | $50.7M | Sell |
214,474
-31,893
| -13% | -$10M | 0.13% | 181 |
|
|
2018
Q4 | $74.1M | Buy |
246,367
+21,274
| +9% | +$6.79M | 0.2% | 105 |
|
|
2018
Q3 | $79.5M | Buy |
225,093
+221,374
| +5,953% | +$76.2M | 0.19% | 119 |
|
|
2018
Q2 | $1.08M | Sell |
3,719
-30
| -0.8% | -$8.43K | ﹤0.01% | 1267 |
|
|
2018
Q1 | $1.03M | Sell |
3,749
-58
| -2% | -$18K | ﹤0.01% | 1219 |
|
|
2017
Q4 | $1.21M | Buy |
3,807
+102
| +3% | +$32.7K | ﹤0.01% | 1152 |
|
|
2017
Q3 | $1.16M | Sell |
3,705
-902
| -20% | -$267K | ﹤0.01% | 1160 |
|
|
2017
Q2 | $1.25M | Sell |
4,607
-3,768
| -45% | -$996K | ﹤0.01% | 1125 |
|
|
2017
Q1 | $2.29M | Sell |
8,375
-3,251
| -28% | -$919K | 0.01% | 856 |
|
|
2016
Q4 | $3.3M | Sell |
11,626
-12,183
| -51% | -$3.61M | 0.01% | 688 |
|
|
2016
Q3 | $7.45M | Sell |
23,809
-4,717
| -17% | -$1.4M | 0.02% | 484 |
|
|
2016
Q2 | $6.9M | Buy |
28,526
+2,702
| +10% | +$712K | 0.02% | 480 |
|
|
2016
Q1 | $6.72M | Sell |
25,824
-18,101
| -41% | -$4.78M | 0.02% | 487 |
|
|
2015
Q4 | $13.5M | Sell |
43,925
-423,936
| -91% | -$122M | 0.04% | 372 |
|
|
2015
Q3 | $137M | Buy |
467,861
+25,599
| +6% | +$8.45M | 0.44% | 46 |
|
|
2015
Q2 | $179M | Buy |
442,262
+516
| +0.1% | +$207K | 0.54% | 36 |
|
|
2015
Q1 | $187M | Sell |
441,746
-49,528
| -10% | -$19.5M | 0.57% | 30 |
|
|
2014
Q4 | $167M | Buy |
491,274
+37,694
| +8% | +$12.2M | 0.52% | 37 |
|
|
2014
Q3 | $150M | Buy |
453,580
+33,801
| +8% | +$11.1M | 0.48% | 40 |
|
|
2014
Q2 | $132M | Sell |
419,779
-4,158
| -1% | -$1.25M | 0.42% | 44 |
|
|
2014
Q1 | $130M | Buy |
423,937
+751
| +0.2% | +$238K | 0.43% | 44 |
|
|
2013
Q4 | $118M | Sell |
423,186
-12,705
| -3% | -$3.29M | 0.41% | 47 |
|
|
2013
Q3 | $105M | Sell |
435,891
-31,059
| -7% | -$6.95M | 0.4% | 47 |
|
|
2013
Q2 | $100M | Buy |
+466,950
| New | +$99.8M | 0.4% | 50 |
|
Other funds holding BIIB
Federated Hermes's BIIB Position: Q2 2026 in Review
Federated Hermes increased its Biogen (BIIB) stake by 1.1% in Q2 2026, buying an estimated $198K and bringing the position to 98,315 shares worth $21.2M. The position accounts for 0.03% of the portfolio, ranked #482.
Federated Hermes first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $187M in Q1 2015. 1,041 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Federated Hermes held 98,315 shares of Biogen worth $21.2M as of Q2 2026.
- Federated Hermes bought 1,036 Biogen shares in Q2 2026, an estimated $198K.
- Biogen made up 0.03% of Federated Hermes's portfolio in Q2 2026, its #482 holding.
- Federated Hermes first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
- Federated Hermes's Biogen position peaked at $187M in Q1 2015.
- 1,041 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.